We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pierrel | BIT:PRL | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Dec 2022 to Dec 2024
(Il Sole 24 Ore Radiocor Plus) - Roma, 09 ott - L'industria farmaceutica Pierrel ha ottenuto l'autorizzazione alla commercializzazione in Uzbekistan per l'anestetico dentale a base di articaina, Orabloc, in entrambe le formulazioni: 1:100.000 e 1:200.000. Lo comunica l'azienda sottolineando che "con questa nuova autorizzazione, Pierrel rafforza la propria presenza commerciale in Asia Centrale". Pierrel esporta i propri anestetici dentali in 37 paesi, ed ha recentemente ampliato il proprio portafoglio prodotti acquisendo la linea di anestetici dentali dell'americana 3M con i brand Ubisestin, Xylestesin e Mepivastesin.
Com-Dif
(RADIOCOR) 09-10-23 09:39:18 (0205)SAN 5 NNNN
(END) Dow Jones Newswires
October 09, 2023 03:39 ET (07:39 GMT)
Copyright (c) 2023 Dow Jones-Radiocor
1 Year Pierrel Chart |
1 Month Pierrel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
